NEUROBLASTOMA - A 32-YEAR POPULATION-BASED STUDY - IMPLICATIONS FOR SCREENING

被引:16
作者
HUDDART, SN
MUIR, KR
PARKES, S
MANN, JR
STEVENS, MCG
RAAFAT, F
机构
[1] CHILDRENS HOSP, DEPT ONCOL, BIRMINGHAM B16 8ET, W MIDLANDS, ENGLAND
[2] CHILDRENS HOSP, DEPT HISTOPATHOL, BIRMINGHAM B16 8ET, W MIDLANDS, ENGLAND
[3] CHILDRENS HOSP, W MIDLANDS REG TUMOUR RES GRP, BIRMINGHAM B16 8ET, W MIDLANDS, ENGLAND
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 1993年 / 21卷 / 02期
关键词
INCIDENCE; CHILDHOOD TUMORS; MALIGNANCY; CATECHOLAMINES;
D O I
10.1002/mpo.2950210204
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper describes a retrospective population-based study of neuroblastoma in the West Midlands Health Authority Region-childhood population 1.12 million (OPCS, census 1981)-in which 239 cases were diagnosed between 1st January 1957 and 31st December 1988. The age standardised rate of tumour incidence has remained constant at 7.2 cases per million children per year. The median age at diagnosis was 2 years with 18% of children presenting before the age of 6 months. Fifty children (21%) presented before the age of one year, and for this group of children, the prognosis has improved significantly over the 32-year period (10 year survival increasing from 63% in 1957-67 to 87% in 1978-88), whereas for the 189 (79%) children who presented after one year of age, the prognosis has remained very poor during the study period (10 year survival 1957-67 = 9.5%, 1978-88 = 8.5%). This study supports the need for a prospective study of mass screening at several intervals rather than only at 6 months of age.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 21 条
[1]  
BELL M, 1976, PRACTICAL CLIN BIOCH, V2, P196
[2]  
BERTHOLD F, 1991, AM J PEDIAT HEMATOL, V13, P8
[3]   IMPROVEMENTS IN SURVIVAL FROM CHILDHOOD-CANCER - RESULTS OF A POPULATION BASED SURVEY OVER 30 YEARS [J].
BIRCH, JM ;
MARSDEN, HB ;
JONES, PHM ;
PEARSON, D ;
BLAIR, V .
BRITISH MEDICAL JOURNAL, 1988, 296 (6633) :1372-1376
[4]   NEUROBLASTOMAS TREATED AT THE 4 MAJOR CHILD ONCOLOGIC CLINICS IN DENMARK 1943-1980 - AN EVALUATION OF 180 CASES [J].
CARLSEN, NLT ;
SCHROEDER, H ;
BRO, PV ;
ERICHSEN, G ;
HAMBORGPEDERSEN, B ;
JENSEN, KB ;
NIELSEN, OH .
MEDICAL AND PEDIATRIC ONCOLOGY, 1985, 13 (04) :180-186
[5]   BIOCHEMICAL SCREENING FOR NEURO-BLASTOMA IN INFANTS - A FEASIBILITY STUDY [J].
CRAFT, AW ;
DALE, G ;
MCGILL, A ;
SEVIOUR, J ;
SPENCE, EM .
MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (05) :373-378
[6]  
CRAFT AW, 1987, LANCET, V2, P1082
[7]  
EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO
[8]  
2-G
[9]  
GOEMANS AJ, 1977, PEDIATRICS, V59, P710
[10]   CURRENT URINARY MASS-SCREENING FOR CATECHOLAMINE METABOLITES AT 6 MONTHS OF AGE MAY BE DETECTING ONLY A SMALL PORTION OF HIGH-RISK NEUROBLASTOMAS - A CHROMOSOME AND N-MYC AMPLIFICATION STUDY [J].
KANEKO, Y ;
KANDA, N ;
MASEKI, N ;
NAKACHI, K ;
TAKEDA, T ;
OKABE, I ;
SAKURAI, M .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (12) :2005-2013